David Hollander - Feb 4, 2022 Form 4 Insider Report for AERIE PHARMACEUTICALS INC (AERI)

Role
Chief R&D Officer
Signature
/s/ John LaRocca, Attorney-in-Fact for David Hollander
Stock symbol
AERI
Transactions as of
Feb 4, 2022
Transactions value $
-$6,535
Form type
4
Date filed
2/8/2022, 07:40 PM
Previous filing
Feb 3, 2022
Next filing
Mar 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AERI Common Stock Tax liability -$6.54K -927 -2.93% $7.05 30.7K Feb 4, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted Common Stock.